- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Eric Anderson on Wearable Technology in Parkinson Disease
Eric Anderson, MD, PhD, vice chair of neurology, quality at SOC Telemed, discusses the growing field of wearable technology for movement disorders like Parkinson disease.
Eric Anderson, MD, PhD, vice chair of neurology, quality at SOC Telemed, discusses the growing field of wearable technology for movement disorders like Parkinson disease.
Transcript:Do you see wearable technology as providing a benefit for patients with Parkinson disease?
So wearable technology in the assessment and diagnosis of Parkinson disease is a growing field, and that’s something that’s certainly gaining a lot of steam. Being able to monitor these patients that are otherwise immobile and require special attention or special time coming into clinic offices is certainly something that is very helpful. I think the telemovement is poised to provide access to movement disorder specialists in many different areas where these physicians don’t exist or these resources don’t exist.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
